Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

1589 results found

2023 ∙ Cazzato, G. Ambrogio, F. Pisani, M. C. Colagrande, A. Arezzo, F. Cascardi, E. Dellino, M. Macorano, E. Trilli, I. Parente, P. Lettini, T. Romita, P. Marzullo, A. Ingravallo, G. Foti, C.

Histopathological Patterns of Cutaneous Adverse Reaction to Anti-SARS-CoV-2 Vaccines: The Integrative Role of Skin Biopsy

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Limbu, Y. B. Gautam, R. K.

How Well the Constructs of Health Belief Model Predict Vaccination Intention: A Systematic Review on COVID-19 Primary Series and Booster Vaccines

  • All age groups
  • Healthcare workers
  • Parents/caregivers
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Alotaibi, A. S. Shalabi, H. A. Alhifany, A. A. Alotaibi, N. E. Alnuhait, M. A. Altheaby, A. R. Alhazmi, A. Y.

Humoral and Cellular Immunity following Five Doses of COVID-19 Vaccines in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Farhadian, N. Sharifi, S. Taghadosi, M. Farhadian, M. Vaziri, S.

Humoral immune response to two doses of COVID-19 mRNA-based vaccines in people living with HIV: A systematic review and meta-analysis

  • Adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Martinelli, S. Pascucci, D. Laurenti, P.

Humoral response after a fourth dose of SARS-CoV-2 vaccine in immunocompromised patients. Results of a systematic review

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Notarte, K. I. Catahay, J. A. Peligro, P. J. Velasco, J. V. Ver, A. T. Guerrero, J. J. Liu, J. Lippi, G. Benoit, S. W. Henry, B. M. Fernández-de-Las-Peñas, C.

Humoral Response in Hemodialysis Patients Post-SARS-CoV-2 mRNA Vaccination: A Systematic Review of Literature

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2023 ∙ Camargo-Coronel, A. Quiñones-Moya, H. Hernández-Zavala, M. R. Hernández-Vázquez, J. R. Vázquez-Zaragoza, MÁ

Idiopathic inflammatory myopathies linked to vaccination against SARS-CoV-2: a systematic review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Shi, H. Sun, J. Zeng, Y. Wang, X. Liu, S. Zhang, L. Shao, E.

Immune escape of SARS-CoV-2 variants to therapeutic monoclonal antibodies: a system review and meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Ho, T. C. Shen, D. H. Chang, C. C. Chan, H. P. Chuang, K. P. Yuan, C. H. Chen, C. N. Yang, M. H. Tyan, Y. C.

Immune Response Related to Lymphadenopathy Post COVID-19 Vaccination

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Cheng, M. Q. Li, R. Weng, Z. Y. Song, G.

Immunogenicity and effectiveness of COVID-19 booster vaccination among people living with HIV: a systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...